Chadi Saifan

Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis

Peter C. Taylor, Michael E. Weinblatt, Gerd R Burmester et al. · Arthritis & Rheumatology · 2019 · 177 citations · Full text

Medicine, Internal Medicine, Pharmacology +14

Safety profile of baricitinib for the treatment of rheumatoid arthritis over a median of 3 years of treatment: an updated integrated safety analysis

Mark C. Genovese, Josef S Smolen, Tsutomu Takeuchi et al. · The Lancet Rheumatology · 2020 · 81 citations

Medicine, Internal Medicine, Pharmacology +14

An Adaptive Randomized Trial of an Intermittent Dosing Schedule of Aerosolized Ribavirin in Patients With Cancer and Respiratory Syncytial Virus Infection

Roy F. Chemaly, Harrys A. Torres, Mark F. Munsell et al. · The Journal of Infectious Diseases · 2012 · 55 citations · Full text

Pharmacy, Pharmacotherapy, Antimicrobial Pharmacotherapy +16

Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials

Masayoshi Harigai, Tsutomu Takeuchi, Josef S Smolen et al. · Modern Rheumatology · 2019 · 55 citations · Full text

Medicine, Internal Medicine, Pharmacology +17

Effects of proton pump inhibitors and electrolyte disturbances on arrhythmias

Chadi Saifan, El-Charabaty, Abdallah et al. · International Journal of General Medicine · 2013 · 41 citations · Full text

Medicine, Cardiology, Pharmacology +17